Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Moderna Inc
(NQ:
MRNA
)
77.40
-0.19 (-0.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
99
100
Next >
Texas Attorney General Alleges Pfizer Misled Public on COVID-19 Vaccine Efficacy
December 01, 2023
Texas Attorney General Ken Paxton has filed a lawsuit against Pfizer Inc (NYSE: PFE), alleging the pharmaceutical giant misrepresented the efficacy of its widely-
Via
Benzinga
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Texas Sues Pfizer For "Misrepresenting COVID-19 Vaccine Efficacy" And "Conspiring To Censor Public Discourse"
November 30, 2023
The Texas attorney general is suing pharmaceutical giant Pfizer for misrepresenting the effectiveness of the company's Covid-19
Via
Talk Markets
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Analyst Expectations for Moderna's Future
November 29, 2023
Via
Benzinga
Feeling Lucky? 5 ‘Jackpot’ Stocks to Buy for 2024.
November 27, 2023
When investors land on a "jackpot" stock, gains can offset even the steepest losses. Here are the top stocks to buy if you're feeling lucky.
Via
InvestorPlace
Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations
November 24, 2023
Several S&P 500 stocks are trading at discounts of over 40% compared to analysts' price targets, offering potential upside, but caution is needed.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
$100 Invested In Moderna 5 Years Ago Would Be Worth This Much Today
November 24, 2023
Via
Benzinga
Big Players' Recent Trades in MRNA Options
November 22, 2023
Via
Benzinga
3 Biotech Stocks That Could Be Millionaire Makers
November 22, 2023
Many biotech stocks offer exciting long-term growth prospects.
Via
The Motley Fool
Half Of S&P 500 Stocks Still Below 200-Day Average, Ignoring Covid-Like Rally: 10 Bargain Plays For Latecomer Bulls
November 21, 2023
Explore the dichotomy in the latest S&P 500 rally: Strong overall performance masks the underperformance of nearly half its stocks.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is COVID-19 Vaccine Maker Moderna Stock Trading Lower Today?
November 21, 2023
Moderna Inc (NASDAQ: MRNA) shares slipped on Tuesday trading after the European Patent Office said a contested mRNA patent owned by Moderna is invalid, marking a victory for Pfizer Inc (NYSE: PFE) /
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Don’t Let the Q3 Earnings Miss Keep You From These 3 Stocks!
November 20, 2023
Few S&P 500 companies didn’t meet or exceed Q3 2023 earnings estimates. Here are three earnings miss investment opportunities.
Via
InvestorPlace
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Big Players' Recent Trades in MRNA Options
November 17, 2023
Via
Benzinga
Peering Into Moderna's Recent Short Interest
November 15, 2023
Via
Benzinga
Where Will Novavax Be in 3 Years?
November 11, 2023
Novavax shares have plunged from early pandemic highs.
Via
The Motley Fool
3 Cathie Wood Bargain Buys That Should Be on Your List Too
November 13, 2023
Wood just picked up shares of these companies recently.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 10, 2023
Via
Benzinga
2 Top Biotech Stocks to Buy Right Now
November 10, 2023
Don't give up on these stocks too fast.
Via
The Motley Fool
Why Moderna Stock Was Cratering This Week
November 10, 2023
Perhaps the COVID-19 vaccine developer's best days are in the past.
Via
The Motley Fool
Exposures
COVID-19
Moderna's Stock Just Tumbled 12%. Here's Why It's Still a Buy.
November 09, 2023
It's gearing up for its next growth spurt.
Via
The Motley Fool
6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367%
November 08, 2023
Wall Street is forever optimistic about the future for stocks and pegs these seven Nasdaq 100 stocks as ready for supersonic growth
Via
InvestorPlace
Moderna Unusual Options Activity For November 08
November 08, 2023
Via
Benzinga
High Risk Alert: 7 Vulnerable Stocks to Dump Now
November 07, 2023
The economy is showing weakness. These seven stocks at risk could be at the center of the coming bust.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
BioNTech Shifted Its Focus To Innovative Oncology And Mainz Biomed Announced A Showcasing Of Its Revolutionary Colorectal Cancer Detection Test
November 07, 2023
On November 6th, BioNTech SE (NASADQ: SE) who partnered with Pfizer Inc (NYSE: PFE) in the making of a blockbuster COVID-19 vaccine, posted a surprise earnings with its latest quarterly report.
Via
Benzinga
Exposures
COVID-19
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year?
November 07, 2023
Should you buy the dip on these S&P 500 stocks?
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Cathie Wood Just Bought This Struggling Stock After Its Billion-Dollar Quarterly Loss. Should You?
November 07, 2023
This particular stock has dropped more than 50% this year.
Via
The Motley Fool
Like Moderna, BioNTech Cuts Annual Sales Forecast By 20% As Pandemic Fades
November 06, 2023
BioNTech SE (NASDAQ: BNTX) has reported Q3 revenues of €895.3 million ($974.49 million), sharply down from €3.461 billion a year ago.
Via
Benzinga
Down 84% From Its Peak. Is It Finally Time to Buy Moderna?
November 05, 2023
The vaccine developer's huge profits have turned into heavy losses.
Via
The Motley Fool
Moderna May Be Facing Its Toughest Moment Ever. Time to Sell?
November 04, 2023
Moderna still has big ambitions -- beyond the coronavirus vaccine -- that could pay off in a few years.
Via
The Motley Fool
Exposures
COVID-19
These Analysts Cut Their Forecasts On Moderna After Q3 Results
November 03, 2023
Moderna Inc (NASDAQ: MRNA) posted a loss for the third quarter on Thursday.
Via
Benzinga
Cyberark Software To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday
November 03, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.